Navigation Links
Sanofi-Aventis Allows Thais To Make Plavix

The generic version of Plavix, the heart disease medicine of Sanofi-Aventis will be made indigenously in Thailand. This was announced by the pharma company on Tuesday.//

As per the offer made by Sanofa-Aventis, the health ministry has approved plans to buy or make imitated version of the drug. The statement released by the drug firm states that indigenous making of the heart drug will benefit the poorer Thai patients. According to a health official the company had offered a special quota of 3.4 million Plavix tablets for 34,000 patients.

The drug industry was shocked last November by the action of Thailand government when it decided to supersede the patent on Efavirenz, a drug for HIV from Merck & Co. Later licenses were issued for Plavix and Kaletra, an AIDS drug from the US pharma giant Abbott Laboratories. But Abbott reacted sharply to this by refusing to launch new drugs in Thailand which was not welcomed by AIDS activists all over the world.

Drug companies do not approve such moves as they are investing a lot of money in research and development and in the formulation of a new drug. Fabrice Baschiera, general manager of Sanofi-Aventis in Thailand said, "The best way to find solutions to difficult health care challenges is to reject confrontation and engage in constructive dialogue with a view to increasing private and public sector partnership."

On the other hand, World Trade Organization permits governments to issue compulsory licenses and allows others to make a patented medicine without the approval of a foreign patent owner. But according to Thailand government essential medicines are too expensive for the country’s health care program.
JYT
'"/>




Page: 1

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. U S Government Allows Non-prescription Diet Pill
4. British Court Allows Argument in Favour of Open-air Funerals
5. Plavix Gets FDA Okay for New Indication
6. Plavix Safe During and After Heart Bypass
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... ... planning services to communities in the greater Chicago metropolitan area, is embarking on ... to underprivileged youth in Chicago. , Founded in 1897, Hephzibah Children’s Association is ...
(Date:6/23/2017)... ... 23, 2017 , ... Radabaugh & Associates, a locally owned ... owners in North Central West Virginia, is embarking on a cooperative charity drive ... in the region. , The Stepping Stones organization offers a series of personal ...
(Date:6/22/2017)... ... 2017 , ... Branches, Inc. has been partnering with The Miami Foundation for ... its programs focused on providing opportunity to low-income families and breaking the cycle of ... of $15,000 to support its , Climb to College & Career initiative which focuses ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered in ... balancing their clients’ risk while tailoring optimized benefit packages that strengthen the relationship ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, with ... and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries and ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
(Date:6/1/2017)... Pa. , June 1, 2017 Nutriceutical ... and Veterinarian Recommended Solutions (VRS), and KD Pharma Group ... in Nutriceutical Holdings by KD Pharma Group. KD Pharma ... with the option to acquire the entire company. ... in KD. They are committed to growing the NH ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
Breaking Medicine Technology: